Islay Capital Management’s Usana Health Sciences USNA Stock Holding History

Islay Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,461	Closed	-$84K	–	311
2020 Q1	$84K	Buy	+1,461	New	+$102K	0.11%	101

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Islay Capital Management's USNA Position: Q2 2020 in Review

Islay Capital Management sold out of Usana Health Sciences (USNA) in Q2 2020, closing a stake of 1,461 shares — an estimated $84K sold.

Islay Capital Management first reported a position in USNA in Q1 2020 and held it in 1 quarter. The position peaked at $84K in Q1 2020. 192 funds tracked by Wall St. Rank hold USNA as of Q2 2020.

Islay Capital Management reported no remaining Usana Health Sciences position as of Q2 2020 after selling out during the quarter.
Islay Capital Management sold 1,461 Usana Health Sciences shares in Q2 2020, an estimated $84K.
Islay Capital Management first reported a position in Usana Health Sciences in Q1 2020 and held it in 1 quarter.
Islay Capital Management's Usana Health Sciences position peaked at $84K in Q1 2020.
192 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2020.

Based on Islay Capital Management's 13F filing for Q2 2020, filed 4 Aug 2020.